HIGHLIGHTS
SUMMARY
The dynamic gut microbiota variation characteristics may be exploited as a potent biomarker to early predictions immunotherapy outcomes in HCC, which is critical for HCC surveillance and cancer immunotherapy decision-making. The number of annual research publications and growth trends on the links of gut microbiota and HCC from 2011 to 2022. In the past 11 years, a total of 1,155 research institutions from 64 countries have published gut microbiota and HCC related publications. According to the Table 2, the authors found that the majority of published articles regarding this topic have their . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.